TRADE CONTROLSBRIEF

Authority, evidence, and operating consequence across borders.

Coverage desk

Country-of-Origin Marking

Source-backed reporting and analysis connected to the companies, capabilities, authorities, and operating domains it affects.

Repacked prescriptions need origin-marking continuity

CBP's fact sheet explains that certain foreign-origin capsules, pills, tablets, lozenges, and troches are excepted from individual marking under the J-List, while the outermost container that ordinarily reaches the ultimate purchaser must show origin. When an in-scope medication is repacked for retail sale, the control question is whether that already-determined origin survives the exact container handoff with the required importer certification and downstream notice.

MIC calculates origin and preference—but a preference result is not supplier-origin evidence

MIC's official product page describes collecting supplier declarations and calculating preferential origin from bills of materials across free-trade agreements, with archived calculations and certificates. A favorable result can support a claim only when the underlying declarations, product structure, rule version, dates, and authorized review remain traceable and valid for the transaction.